info@marketfacts.ca +1-807 788 8478
Electronic Arts Inc. (NASDAQ: EA) is a leading American video game company headquartered in Redwood City, California. Founded in 1982 by former Apple employee Trip Hawkins, EA has been a key player in the interactive entertainment industry, developing and publishing games for consoles, PCs, and mobile devices.
Cal-Maine Foods, Inc. (NASDAQ: CALM) is the largest producer and distributor of fresh shell eggs in the United States. Founded in 1957 and headquartered in Ridgeland, Mississippi, the company supplies eggs to various retail and foodservice customers across the country. Cal-Maine operates a vertically integrated business model, managing all aspects of production, from breeding and hatching to feeding,
Anavex Life Sciences Corp. (NASDAQ: AVXL) is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for central nervous system (CNS) disorders, with a primary focus on Alzheimer’s disease, Parkinson’s disease, and Rett syndrome. The company’s proprietary SIGMACEPTOR™ platform leverages sigma-1 receptor (S1R) agonists to restore cellular homeostasis, targeting key mechanisms such as oxidative stress, inflammation, and mitochondrial dysfunction.
OneSpan Inc. (NASDAQ: OSPN) is a cybersecurity company that provides solutions for digital identity verification, authentication, and fraud prevention. It specializes in securing online transactions, protecting sensitive data, and ensuring the integrity of digital communications.
Reynolds Consumer Products Inc. (NASDAQ: REYN) Reynolds Consumer Products Inc. has a long and storied history that dates back to 1919 when Richard S. Reynolds, Sr. founded the Reynolds Metals Company, initially focusing on aluminum production. The company expanded into consumer goods, introducing Reynolds Wrap® aluminum foil in 1947, which became an essential kitchen product in American households.
Exelon Corporation (NASDAQ: EXC) is one of the largest regulated electric utilities in the United States, headquartered in Chicago, Illinois. Originally formed in 2000 through the merger of PECO Energy Company and Unicom, Exelon provides electricity and natural gas to over 10 million customers across Illinois, Pennsylvania, Maryland, Delaware, New Jersey, and Washington, D.C.
NewtekOne Inc (NASDAQ: NEWT) established in 1998 and headquartered in Boca Raton, Florida, has evolved significantly over the years. Originally known as Newtek Business Services Corp., the company rebranded to NewtekOne, Inc.
GoodRx Holdings, Inc. (NASDAQ: GDRX) is a healthcare technology company based in Santa Monica, California, that helps consumers access affordable medications and healthcare services. Founded in 2011, GoodRx operates a platform that provides price comparison tools for prescription drugs, enabling users to find discounts at thousands of pharmacies across the United States.
Tandem Diabetes Care, Inc. (TNDM) Tandem Diabetes Care, Inc., founded in 2006 and headquartered in San Diego, California, is a medical technology company specializing in insulin pump systems for people with diabetes. Their flagship product, the t:slim X2 Insulin Pump, integrates with continuous glucose monitoring (CGM) systems like Dexcom G6 and features advanced technologies such as Control-IQ and Basal-IQ for automated insulin delivery and predictive low-glucose suspension.
Arbutus Biopharma Corporation (NASDAQ: ABUS) is a clinical-stage biopharmaceutical company headquartered in Warminster, Pennsylvania, focused on developing innovative therapies to treat chronic hepatitis B virus (HBV) infection. The company aims to achieve a functional cure for HBV by targeting multiple stages of the virus lifecycle through a combination of RNA interference (RNAi) therapies, capsid inhibitors, immune modulators, and HBV RNA destabilizers. Its lead product candidates include AB-729, an RNAi therapeutic designed to reduce hepatitis B surface antigen (HBsAg), and AB-836, a capsid inhibitor. Leveraging proprietary lipid nanoparticle (LNP) technology for RNA-based therapies, Arbutus is also engaged in collaborations to advance its pipeline. Arbutus is strategically positioned in the biopharmaceutical landscape, aiming to address unmet medical needs in HBV treatment. By pursuing a comprehensive approach that integrates cutting-edge science and collaboration, Arbutus continues to advance its pipeline and work toward transformative solutions for HBV patients globally.